High-risk human papillomavirus DNA Test: Could it be useful in low-grade cervical lesion triage? Five-year follow-up

Reproductive Sciences

Volumn 21, Issue 2, 2014, Pages 198-203

  Saccardi, Carlo ^a   Gizzo, Salvatore ^a   Noventa, Marco ^a   Anis, Omar ^a   Gangi, Stefania Di ^a   Patrelli, Tito Silvio ^b   D'Antona, Donato ^a   Nardelli, Giovanni Battista ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

colposcopy; follow up; hrHPV DNA test; infection disease; L SIL triage; mild dyskaryosis

Indexed keywords

ARTICLE; COLPOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

COLPOSCOPY; FOLLOW-UP; HRHPV-DNA TEST; INFECTION DISEASE; L-SIL TRIAGE; MILD DYSKARYOSIS;

ADULT; ALPHAPAPILLOMAVIRUS; CERVIX UTERI; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TRIAGE;

EID: 84901796724     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113492214     Document Type: Article

References (35)

1. Cotton SC, Sharp L, Little J, et al. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemp Clin Trials. 2006 ; 27 (5). 449-471
2. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D.. Consensus conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007 ; 197 (4). 346-355
3. Corrêa Fde M, Russomano FB, Oliveira CA. Colposcopic triage methods for detecting cervical intraepithelial neoplasia grade 3 after cytopathological diagnosis of low-grade squamous intraepithelial lesion: a systematic review on diagnostic tests. Sao Paulo Med J. 2012 ; 130 (1). 44-52
4. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ. 2009 ; 339: b2546
5. Hellsten C, Sjöström K, Lindqvist PG. A 2-year follow-up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear. BJOG. 2008 ; 115 (2). 212-218
6. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006 ; 110 (5). 525-541
7. Cotton S, Sharp L, Little J, et al. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG. 2010 ; 117 (6). 645-659
8. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003 ; 188 (6). 1393-1400
9. Cox JT, Schiffman M, Solomon D. ASCUS-LSIL Triage Study (ALTS)Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003 ; 188 (6). 1406-1412
10. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008 ; 26: suppl K29 - K41
11. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006 ; 24 (suppl 3). 78 - S89
12. Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006 ; 98 (11). 765-774
13. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006 ; 7 (7). 547-555
14. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010 ; 11 (3). 249-257
15. Frederiksen M, Lynge E, Rebolj M.. What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review. BJOG. 2012 ; 119 (1). 7-19
16. Rana DN, Marshall J, Desai M, et al. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears. Cytopathology. 2004 ; 15 (5). 263-270
17. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, et al. Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature. Cancer Treat Rev. 2007 ; 33 (6). 514-520
18. La Colposcopia in Italia. Società italiana di Colposcopia e Patologia Cervico Vaginale. Linee Guida Edizione 2006. "Gestione delle pazienti con Pap-test anormale". Anno XXI. http://www.colposcopiaitaliana. it/pdf07/Linee-Guida-2006.pdf. Accessed December 1, 2006.
19. La Colposcopia in Italia. Società italiana di Colposcopia e Patologia Cervico Vaginale. Linee Guida Edizione 2002. "Gestione delle pazienti con Pap-test anormale". Anno XIX. http://www.colposcopiaitaliana. it/pdf07/Linee-Guida-2002.pdfAccessed December 1, 2002.
20. Carozzi FM, Del Mistro A, Confortini M, et al. Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol. 2005 ; 124 (5). 716-721
21. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003 ; 326 (7395). 901-905
22. Luesley D, Leeson S. Colposcopy and Programme Management. Guidelines for the NHS Cervical Screening Programme. Sheffield, England: NHS Cervical Screening Programmes ; 2004 :
23. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 ; 119 (5). 1095-1101
24. Naucler P, Ryd W, Törnberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007 ; 357 (16). 1589-1597
25. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007 ; 370 (9601). 1764-1772
26. Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. 2009 ; 10 (7). 672-682
27. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst. 2000 ; 92 (5). 397-402
28. Moss S, Gray A, Legood R, et al. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ. 2006 ; 332 (7533). 83-85
29. Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med. 2009 ; 13 (4). 648-659
30. Bentley E, Cotton SC, Cruickshank ME, et al. Refining the management of low-grade cervical abnormalities in the UK National Health Service and defining the potential for human papillomavirus testing: a commentary on emerging evidence. J Low Genit Tract Dis. 2006 ; 10 (1). 26-38
31. Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E. A comparison of the human papillomavirus test and Papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand. 2005 ; 84 (10). 996-1000
32. Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP.. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998 ; 92 (4 pt 2). 727-735
33. Moscicki AB, Shiboski S, Hills NK, et al. Regression of low grade squamous intra-epithelial lesions in young women. Lancet. 2004 ; 364 (9446). 1678-1683
34. Confortini M, Carozzi F. Prevenzione del carcinoma della cervice uterina -dal test HPV al vaccino - le nuove strategie. 1 st ed. Milano, Italy: Elsevier; 2012. Milano, Italy: Elsevier ; 2012 :
35. Arbyn M, Roelens J, Simoens C, et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev. 2013 ; 3: CD008054